[Markers of malignant potential and clinical management of dysplasia in Barrett esophagus].
Roth
J A
JA
Department of Thoracic Surgery, M. D. Anderson Cancer Center, Houston, Texas.
Hölscher
A H
AH
Schneider
P M
PM
D000230:Adenocarcinoma / Q000473:pathology* / Q000601:surgery; D001471:Barrett Esophagus / Q000473:pathology* / Q000601:surgery; D014408:Biomarkers, Tumor / Q000032:analysis; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D004947:Esophagus / Q000473:pathology / Q000601:surgery; D005500:Follow-Up Studies; D005764:Gastroesophageal Reflux / Q000473:pathology / Q000601:surgery; D006801:Humans; D011230:Precancerous Conditions / Q000473:pathology* / Q000601:surgery
D014408:Biomarkers, Tumor
Marker des malignen Potentials und klinisches Management von Dysplasien im Barrett-Oesophagus.